GLPwatch
Trials (2036)
Page 34 of 34.
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
- Semaglutide Treatment in Type 1 Diabetes
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
- A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
- Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
- Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss
- Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
- A Study of HS-20094 in Patients With T2DM
- Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
- Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
- Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
- Effects of Liraglutide on Body Surface Gastric Mapping
- Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
- Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
- Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- Liraglutide in Adolescents With Type 1 Diabetes
- Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- Semaglutide for Alcohol Use Disorder
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
- Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
- Bariatric Surgery vs. Semaglutide vs. Tirzepatide
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Binge Eating Liraglutide Intervention
- Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
- Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- Treating PCOS With Semaglutide vs Active Lifestyle Intervention
- Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
- The Medically Reproducing Bariatric Surgery (MRB) II Study
- Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
- Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
- Semaglutide and Physical Activity for Obesity and Multimorbidity
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
- Safety Evaluation of Adverse Reactions in Diabetes
- Effect of Semaglutide in Patients With Psoriasis and Obesity
- Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
- Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
- A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
- VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
- Phase 1 Study to Evaluate the Safety and Tolerability of VK2735
- The Effects of Bethanechol on Glucose Homeostasis
- Lifestyle Change Implementation Research Network at PRC at UMass Chan
- A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)
- Effect of Lower Doses of Colonic Nutrient Supplementation on Appetite Hormones and Food Intake in Obese Adults
- VK2735 for Weight Management Phase 2
- Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
- A Study of TG103 Injection in Overweight or Obesity